Ibrance
palbociclib
- Strength
- 75 mg/1
- Form
- Capsule
- Class
- Kinase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Ibrance
palbociclib
Listed by U.S. Pharmaceuticals
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Palbociclib 100 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 63539-486 |
| FDA application | NDA212436 |
| RxNorm concept | 2284102 |
| Package sizes listed | 1 |
| Marketed since | March 2020 |
Other products containing Palbociclib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Ibrance
palbociclib
- Strength
- 125 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
U.S. Pharmaceuticals
Ibrance
palbociclib
- Strength
- 75 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
U.S. Pharmaceuticals
Ibrance
palbociclib
- Strength
- 125 mg/1
- Form
- Capsule
- Class
- Kinase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Ibrance
palbociclib
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Ibrance
palbociclib
- Strength
- 75 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Ibrance
palbociclib
- Strength
- 100 mg/1
- Form
- Capsule
- Class
- Kinase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Ibrance
palbociclib
- Strength
- 125 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.